Merck & Co. Other Segment Items increased by 68.0% to -$138.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 494.3%, from $35.00M to -$138.00M. Over 3 years (FY 2021 to FY 2025), Other Segment Items shows a downward trend with a -51.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase in income signals positive non-operating performance, while an increase in expense signals drag from peripheral activities.
This metric captures miscellaneous income or expense items that are not directly related to the core operational activit...
Similar to 'Other Income/Expense' found in standard income statements; peers often group these items to isolate core operating margin.
is_mrk_other_segment_items| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $103.00M | $450.00M | $340.00M | -$708.00M | -$438.00M | -$429.00M | $0.00 | -$89.00M | -$172.00M | -$126.00M | -$79.00M | $33.00M | -$42.00M | $162.00M | $35.00M | $7.00M | $238.00M | -$431.00M | -$138.00M |
| QoQ Change | — | +336.9% | -24.4% | -308.2% | +38.1% | +2.1% | +100.0% | — | -93.3% | +26.7% | +37.3% | +141.8% | -227.3% | +485.7% | -78.4% | -80.0% | >999% | -281.1% | +68.0% |
| YoY Change | — | — | — | — | -525.2% | -195.3% | -100.0% | +87.4% | +60.7% | +70.6% | — | +137.1% | +75.6% | +228.6% | +6.1% | +116.7% | +46.9% | — | -494.3% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Pharmaceutical | -$14.00M | -$27.00M | $163.00M | -$49.00M | -$21.00M | -$60.00M | $295.00M | -$55.00M |
| Animal Health | $1.00M | $1.00M | -$4.00M | -$1.00M | $0.00 | -$1.00M | — | $0.00 |
| Total | -$42.00M | $162.00M | — | $35.00M | $7.00M | $238.00M | -$431.00M | -$138.00M |
Animal Health, Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.